Chapter 291 Dongchen Enters the United States (Part 2)
After Bruce announced the official start of the authorization ceremony, Long Xiaoyue, who was ready, took the stage at the same time as the FDA signing representative. According to the process planning, after the official start, the representative of Dongchen Pharmaceutical spoke first, and then the FDA signing representative.
The speeches of both parties will be conducted in an official tone. However, due to Bruce's reasons, appropriate personal elements have been added to the speeches of both parties.
The first person to speak was Long Xiaoyue. When she walked to the podium, hugged Bruce gently, and said to the hundreds of media below: "I am very happy to represent Dongchen Pharmaceutical in this meaningful event.
Authorization ceremony. As we all know, the Qushi Bone-setting Patch developed and produced by Dongchen Pharmaceutical has created a miracle in the world's medical field and has completely ended the medical practice of incurable arthritis. This time, the US FDA affirmed the Qushi Bone-setting Patch.
, it also means that our Chinese patent medicines and traditional Chinese medicine methods have begun to be accepted and recognized by the world, which makes us very happy. However, due to production reasons, our products have not been exported abroad. However, in the Ambassador
Mr.’s constant invitations and FDA’s affirmation made us realize that the time is ripe to open foreign markets.”
When Long Xiaoyue said this, she paused deliberately and then said: "Now, we are constantly expanding our production capacity and preparing to fully respond to overseas markets. Today's authorization ceremony is Dongchen Pharmaceutical's first step towards overseas markets.
Going forward, we sincerely hope that the Qushi Bone-setting Patch can truly benefit American patients as soon as possible, and Dongchen will continue to be committed to serving patients around the world."
Long Xiaoyue was making an official speech for Dongchen on the stage. However, many reporters in the audience recognized Long Xiaoyue's identity. Isn't this person the most popular CEO of Dongchen Automobile some time ago?! She was
I personally went to Dresden, and there are also photos of her on top-gear...
Reporters with a keen sense of smell immediately noticed that Dongchen Pharmaceutical and Dongchen Automobile must come from the same invisible group. The authorization ceremony has not yet entered the final signing phase. This news has spread rapidly through the feedback of reporters from various media outlets.
Come on.
After such a long period of continuous accumulation, Dongchen Pharmaceutical has already gained a very good reputation in the country. However, since Dongchen Pharmaceutical's product is a bone-setting patch for removing dampness, the word "Dongchen Pharmaceutical" is mostly just used in
It spreads among patients and their families. However, recently, Dongchen Pharmaceutical has entered the U.S. market with an absolutely high profile, and the ambassador to China personally mediated, and the FDA went to the country to sign the contract and personally acted as an agent in the United States. Therefore, Dongchen Pharmaceutical temporarily
It has also become a hot term in the eyes of the public. Previously...the program for Dongchen Automobile made Dongchen Automobile quickly known to people all over the world. Now both companies have a very high reputation, and today's authorization
During the ceremony, it was suddenly revealed that the two companies had the same CEO, which shocked the public even more!
Not only the public was surprised, but even the media was shocked. They couldn't help but ask themselves: What kind of group is Dongchen? Its two companies are both extremely powerful in their respective fields?
The FDA's signing representative also delivered a short speech on the podium, in which he highly affirmed the efficacy of the dampness-removing and bone-setting patch and expressed the United States' urgent desire for this drug. Similarly, the FDA also thanked Ambassador to China Bruce
After playing a decisive role in this incident, both parties signed a licensing agreement in front of the media, and the signing ceremony was officially completed!
The Americans who got the contract were very happy. As far as the FDA is concerned, they have the exclusive right to operate the anti-dampness bone-setting patch in the United States, which means that they have the absolute right to decide on the distribution of the anti-dampness and bone-setting patch in the domestic market, and the US government has also passed
The subsidy policy has been adopted, giving them sufficient profit margins. Although this breaks the FDA's rules, it is beneficial to the FDA.
The happiest person is Bruce. This time he really plays the role of a good official who cares about the American people. For the American people, such trivial things can greatly increase their good impression of politicians. If there is
One day, Bruce will return to the United States to run for President of the United States. I am afraid that most patients in the United States who have benefited from the Shishi-Removing and Bone-setting Patch will have full confidence in him.
After the signing ceremony, the reporters at the scene strongly requested to add a question and answer session. Bruce asked Zhang Wenhao for advice privately, but Zhang Wenhao did not object at all and agreed to the request.
In the additional question and answer session for reporters, Dongchen, representatives from both sides of the FDA, and Bruce all participated. However, the reporters' questions without exception all revolved around the word Dongchen.
CNN's reporter in China was the first to get the microphone, and then he couldn't wait to ask his question: "I would like to ask Ms. Long, you have appeared as the CEO of Dongchen Motors in a previous top-gear program.
, and now that you have attended this authorization ceremony as the CEO of Dongchen Pharmaceutical, does this indicate that Dongchen Automobile and Dongchen Pharmaceutical actually belong to the same company?"
Long Xiaoyue smiled slightly, nodded and said: "Yes, Dongchen Automobile and Dongchen Pharmaceutical are two completely unrelated companies in a legal sense. The two companies have no overlap in their accounts and business, but this
The two companies are indeed from the same origin, and we have plans to establish Dongchen Group in the near future, at which time we will formally integrate all our subsidiaries."
A reporter from CCTV asked: "Ms. Long, you just said that Dongchen Group will be established and all its subsidiaries will be integrated. So I would like to ask, Dongchen currently has Dongchen Automobile and Dongchen Pharmaceutical.
Are there other subsidiaries? If so, can you disclose the fields that other subsidiaries are involved in? "
Long Xiaoyue did not deny it, saying: "According to our development strategy, some subsidiaries have not yet reached the best time to exit. If we think the time is ripe, we will naturally announce the specific situation."
A reporter from Hong Kong asked: "Ms. Long, according to international experts, Dongchen Automobile's technological strength has surpassed the current automobile manufacturing level by 5 to 10 years, and Dongchen Pharmaceutical has also developed a drug that can cure arthritis."
The good medicine is also defined as an incredible miracle in the medical field. Therefore, I am very curious about Dongchen’s technological strength. What exactly enabled Dongchen to achieve such great achievements in such a short period of time?
?”
Long Xiaoyue said: "I think the outside world's view of Dongchen is somewhat subjective, whether it is Dongchen Pharmaceutical or Dongchen Automobile. Everyone feels that such a young company has suddenly achieved such high results.
It seems a little difficult to understand, but the efforts we made when we were not known to the public were not visible to the outside world."
Media reporters also knew the implication of Long Xiaoyue's words. She meant that although Dongchen was established not long ago, the efforts behind Dongchen's short-term success are something that others cannot see.
At this time, Long Xiaoyue took the initiative and said: "We have a strong scientific research team, and this team has always been positioned behind the scenes. We will never make our core team public to the world, but... I believe that we will have better results in the future."
More and more products will be introduced to the market. By then, I think everyone will be able to know how powerful our scientific research team is through our products."
A British media asked: "Ms. Long, I heard that Dongchen Automobile will officially go on sale in the next step, so I would like to ask, in addition to Dongchen Pharmaceutical, does Dongchen Automobile have a clear product
Export plan? I think since that top-gear program was broadcast, consumers in many countries are looking forward to Dongchen Automobile."
Long Xiaoyue nodded and replied: "From our own point of view, we very much hope to open overseas markets as soon as possible and transport more Dongchen products to the global market, but this must also depend on our own production capacity.
Measured against strength, so I cannot give you a specific deadline for this issue, but I can give you a promise, that is, Dongchen will do its best to bring the best things to everyone in the world who favors Dongchen.
of users.”
This authorization ceremony has once again made Dongchen the focus of public opinion. The public opinion effect obtained by 1+1 is even several times greater than its own influence. Although Dongchen Group has not been officially established, in the eyes of the world,
This group has become synonymous with magic. The reason why it is called magic is because the foreseeable profits of Dongchen Group are already astonishingly huge!
Some economists have begun to estimate that the global profit margin of Qushi Bone-setting Patch should be more than tens of billions of dollars. This is a rough estimate based on the current number of arthritis patients, not including new patients.
, and Dongchen Automobile is even more amazing. Their products have absolutely leading technical levels and market competitiveness in the global market. Their biggest advantage is unparalleled economy. Therefore, their products can definitely be used in the field of mid- to low-end automobiles.
If every competitor is squeezed out, the profit margin in this market alone will reach at least 100 billion U.S. dollars. Among them, the market profit of Toyota alone will reach 10 billion U.S. dollars.
In the eyes of economists, Dongchen Automobile itself is a very destructive company. Because it has unparalleled competitiveness, once its cars start selling and officially invade the automobile market, it may set off a financial storm.
, these days, the stock prices of Chinese joint venture brands and local car brands have begun to decline one after another. If Dongchen Automobile is officially launched in China in January, I am afraid that the stock prices of these companies will definitely plummet, even for brands positioned below 150,000 yuan.
It is also necessary to further compress its profit margins and use price differences to retain potential customers. Companies whose product lines are in direct conflict with Dongchen will basically suffer disaster.
An automobile market expert even published an article, which pointedly pointed out that after Dongchen officially invades the existing automobile brands in the Chinese market, they will either compress their profit margins to the extreme and enter into a price war with Dongchen, or they will
When Dongchen's production capacity is not enough to meet the market demand, we take the opportunity to get the last pot of gold, because once Dongchen's production capacity is enough to meet the domestic market, other brands will completely lose their competitiveness!
The possible result of this is that all car brands will suffer a huge impact, with profits plummeting or even losses. Over time, some companies will be unable to support themselves. By then, the assets of all companies evaporated from the stock market may reach
Hundreds of billions, and hundreds of thousands of employees may be directly affected, breaking the balance of the market, and the consequences will be very terrible! Therefore, he believes that Dongchen is a key player in the automobile market.
A nuclear bomb, and the entire industry will undergo earth-shaking changes because of him.
Zhang Wenhao also understands in his heart that when the technological strength exceeds that of his competitors by a large margin, the entire market will be reshuffled, which will definitely bring a huge impact. Not to mention the industrial field as large as the automobile market, just the dehumidification and bone-setting patch alone will have a huge impact.
As a result, many hospitals in the country have experienced a significant drop in revenue from joint diseases, and some hospitals have even stopped all treatments for arthritis. More than 80% of domestic plaster companies and arthritis drug manufacturers have been hit hard, either by suspending production, going bankrupt, or...
Be merged or reduced to doing work for others.
If Dongchen Automobile's production capacity is enough to cover the global market, then I don't know how many of today's most powerful automobile companies will be on the verge of bankruptcy, and more than one million related employees around the world will lose their jobs, but this is an inevitable result of technological development.
Zhang Wenhao doesn't feel the least bit guilty about this.
Dongchen Group is at the forefront of public opinion, but its actions have not slowed down at all. On the contrary, it has even begun to accelerate!
One million dampness-removing and bone-setting plasters were prepared in just five days, doubling the estimated ten-day deadline. These plasters were shipped directly to the United States by air freight, which also indicates that the production capacity of the dampness-removing and bone-setting plasters has been increased again.
Huge development, as soon as the one million plasters were released, the FDA conducted sampling tests on these plasters. After no problems were found, the FDA immediately advanced the payment for one million dampness-removing and bone-setting plasters.
After the FDA received the anti-dampness bone-setting patch, it took the lead in cooperating with national hospitals. Only national hospitals had the opportunity to obtain the early quota. This also benefited the national hospitals that had always been on good terms with the FDA. Although they were selling the anti-dampness bone-setting patch,
In the process, they cannot earn even a penny of profit, but this will effectively enhance the competitiveness of state hospitals and private hospitals.
On the same day that the anti-dampness bone-setting patch was launched in the United States, all companies producing artificial joints in the United States announced a shutdown at the same time...
{Piaotian Literature www.piaotian.net thanks all book friends for their support, your support is our greatest motivation}
